HLA-B and glomerulonephritis: Individuals from the glomerulonephritis group possessing both variants of KIR2DS4 and perfect HLA-B,-DR matching had about 15 times higher chance of rejection than analogous persons from the non-glomerulonephritis group (see Figure 7, both panels).